Heparin and the Reduction of Thrombosis (HART) Trial

Completed · Not applicable · Has a placebo group

Conditions studied: Thrombosis

In brief

Heparin is frequently used in central venous catheters (CVCs) in post-operative cardiac patients. It remains unclear if a heparin infusion, compared to a normal saline infusion, prevents thrombosis of CVCs after surgery. This study will answer the question: does a low-dose heparin infusion (10 units/kg/h) prevent thrombosis, compared to a normal saline infusion, in patients less than one year of age after cardiac surgery?

Key facts

Study ID

NCT00779558

Run by

Stanford University

People needed

90

Starts

2005-11-01

Expected to finish

2007-11-01

Last updated by the study team

2015-06-12

Who can join

Age: 0 and older, up to 1. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All infants < 1 year of age undergoing cardiac surgery at Lucile Packard Children's Hospital \& #xA

You may not qualify if…

• Known coagulopathy
• History of clinically significant bleeding (GI, cranial, pulmonary)
• Need for therapeutic heparinization
• ECMO

Where it is running

• Stanford University School of Medicine — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.